Article
Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway.
British journal of pharmacology - 1 Apr 2008
Zheng J-M, Zhu J-M, Li L-S, Liu Z-H
Abstract excerpt
BACKGROUND AND PURPOSE: Rhein, an anthraquinone compound isolated from rhubarb, has been proved effective in treatment of experimental diabetic nephropathy (DN). To explore the mechanism of its therapeutic effect on DN, rhein was tested for its effect on the hexosamine pathway. EXPERIMENTAL APPROACH: The influence of rhein on cellular hypertrophy, fibronectin synthesis, glucose uptake, glutamine: fructose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
